Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.

Waystar Holding Corp.

The latest update is out from Rai Way S.p.A. ( ($IT:RWAY) ). Rai Way S.p.A. has published the lists of candidates for the renewal of its Board of D...

Rai Way Publishes Board Candidate Lists Ahead of April Shareholders’ Meeting

The latest update is out from Rai Way S.p.A. ( ($IT:RWAY) ). Rai Way has made available to the public its 2025 Annual Financial Report, including d...

Rai Way Publishes 2025 Annual Report and Governance Documentation Ahead of 2026 Meeting

Rai Way S.p.A. ( ($IT:RWAY) ) just unveiled an announcement. Rai Way S.p.A. has made its Annual Financial Report for the 2025 financial year public...

Rai Way Publishes 2025 Annual Financial Report and Governance Documentation

Lifeway Foods (($LWAY)) has held its Q4 earnings call. Read on for the main highlights of the call. Lifeway Foods’ latest earnings call painted a s...

Lifeway Foods Earnings Call Signals Accelerating Growth

Analysts have been eager to weigh in on the Technology sector with new ratings on Novanta (NOVT) and Waystar Holding Corp. (WAY). Novanta (NOVT) In...

Analysts Have Conflicting Sentiments on These Technology Companies: Novanta (NOVT) and Waystar Holding Corp. (WAY)

Rai Way S.p.A. ( ($IT:RWAY) ) just unveiled an update. Rai Way S.p.A. has made available to the public the documentation for its Ordinary Sharehold...

Rai Way Publishes Documentation Ahead of April 2026 Shareholders’ Meeting

In a report released yesterday, Richard Wiles from Morgan Stanley maintained a Sell rating on Commonwealth Bank of Australia, with a price target o...

Morgan Stanley Sticks to Their Sell Rating for Commonwealth Bank of Australia (CBA)

Rai Way S.p.A. ( ($IT:RWAY) ) has shared an announcement. Rai Way reported 2025 core revenues of €282.8 million, up 2.4%, and Adjusted EBITDA of €1...

Rai Way Lifts EBITDA Above Forecasts, Funds Diversification While Holding Rich Dividend

Macquarie analyst maintained a Sell rating on Commonwealth Bank of Australia today and set a price target of A$120.00. In a report released on Marc...

Macquarie Keeps Their Sell Rating on Commonwealth Bank of Australia (CBA)

An announcement from Shenwan Hongyuan (H.K.) Limited ( ($HK:0218) ) is now available. Shenwan Hongyuan (H.K.) Limited has signaled a sharp turnarou...

Shenwan Hongyuan (H.K.) Flags Return to Profit on Strong Core Business Growth

Rai Way S.p.A. ( ($IT:RWAY) ) has provided an update. Rai Way has convened its ordinary shareholders’ meeting for 28 April 2026 in Rome, setting a ...

Rai Way Calls 2026 Shareholders’ Meeting to Approve Accounts and Renew Governance

In a report released on March 17, Matthew Wilson from Jarden maintained a Sell rating on Commonwealth Bank of Australia, with a price target of A$9...

Commonwealth Bank of Australia (CBA) Gets a Sell from Jarden

An update from Rai Way S.p.A. ( ($IT:RWAY) ) is now available. Rai Way S.p.A. has convened its ordinary shareholders’ meeting for 28 April 2026 in ...

Rai Way S.p.A. ( ($IT:RWAY) ) has provided an announcement. Rai Way’s board of directors has called an ordinary shareholders’ meeting for 28 April ...

Rai Way Calls April 2026 Shareholders’ Meeting for Governance and Capital Measures

Uber Technologies ($UBER) is partnering with Amazon’s ($AMZN) autonomous-vehicle subsidiary, Zoox, to bring fully driverless robotaxis to its ride-...

Uber Doubles Down on Robotaxis with Amazon’s (AMZN) Zoox in Bold Driverless Deal

Brainsway ( ($BWAY) ) has provided an update. On March 11, 2026, BrainsWay reported strong fourth quarter and full‑year 2025 results, with Q4 reven...

BrainsWay Posts Record 2025 Results and Issues Bullish 2026 Outlook on Deep TMS Momentum

Brainsway ($BWAY) announced an update on their ongoing clinical study. The study A Prospective, Randomized, Controlled, Multicenter Trial tests a n...

Market Cap	$6.22B	P/E Ratio	15.66
52W High	$42.55	52W Low	$21.13
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	69.0%	52W Position	8.1%
Overall Score	43	Value Score	60
Quality Score	60	Technical Score	10

EPS Current Est	$1.46	EPS Next Est	$1.64
EPS Growth Est	+12.3%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	WAY	$22.86	0.00%	1.69M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	WAY	$22.86	0%	1.69M
3
4
5
6

WAY

WAY

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Waystar Holding Corp. Data in Excel

Get Waystar Holding Corp. Data in Excel